Delivery Order SPE2DB20D3104-SPE2DB22FV6T8
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,798.78 firm-fixed-price contract is for the delivery of 100 tablets of 27 mg extended-release methylphenidate, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a completion date of July 2, 2024. This delivery order is part of a larger...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,293.70 firm-fixed-price contract is for the delivery of 100 tablets of 27 mg methylphenidate extended-release, a drug used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 36 mg methylphenidate extended-release tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed price of $1,614.66 and a completion date of May 21, 2025. The contract is not set aside for any specific business type....
- This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The order is for 100 units of methylphenidate extended-release 36 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The fixed-price contract has a ceiling value of $1,276.43 and a performance period ending on July 16, 2025. The order is not designated as a set-aside contract. AmerisourceBergen...
- This is a $2,875.43 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The order is for 100 tablets of 36 mg extended-release methylphenidate, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,888.03, is for the delivery of 54 mg Methylphenidate Extended Release (ER) tablets, a medication commonly used to treat Attention Deficit Hyperactivity Disorder (ADHD). The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,414.83, is for the delivery of 18 mg extended-release methylphenidate tablets, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a period of performance through October 24, 2024 and is structured as a firm fixed-price...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,681.22 firm-fixed-price delivery order is for the supply of 4,566,504,596 tablets of 27mg extended-release methylphenidate, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
- This federal contract award, valued at $1,409.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 tablets of 54 mg Methylphenidate Extended Release, a medication used to treat ADHD. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award, valued at $2,282.57, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 54mg methylphenidate extended-release tablets, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is structured as a delivery order and is priced on a firm-fixed-price basis. It does not have...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB22FV6T8Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,273.72 firm-fixed-price contract is for the delivery of 36 mg methylphenidate extended-release tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 5/6/22 |